FcRn-Driven Nanoengineered Mucosal Vaccine with Multi-Epitope Fusion Induces Robust Dual Immunity and Long-Term Protection Against <i>Brucella</i>

Background: Brucellosis poses a significant public health challenge, necessitating effective vaccine development. Current vaccines have limitations such as safety concerns and inadequate mucosal immunity. This study aims to develop an FcRn-targeted mucosal <i>Brucella</i> vaccine by fusi...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Tingting Tian, Yuejie Zhu, Kaiyu Shang, Huidong Shi, Ruixue Xu, Mingzhe Li, Fuling Pu, Junyu Kuang, Jianbing Ding, Fengbo Zhang
Format:	Article
Language:	English
Published:	MDPI AG 2025-05-01
Subjects:	FcRn: neonatal Fc receptor MEV: multi-epitope vaccine mucosal vaccine
Online Access:	https://www.mdpi.com/2076-393X/13/6/567